Cite
HARVARD Citation
Liu, X. et al. (2022). Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy. Journal for immunotherapy of cancer. 10 (4), p. . [Online].